Abstract

Xiaoxuming decoction (XXMD) has been traditionally used to manage stroke though debates on its clinical efficacy were present in the history. Till nowadays, it is still one of the most commonly used herbal recipes for stroke. One of the reasons is that a decent proportion of ischemic stroke patients still have residue symptoms even after thrombolysis with rt-PA or endovascular thrombectomy. Numerous clinical studies have shown that XXMD is an effective alternative therapy not only at the acute stage, but also at the chronic sequelae stage of ischemic stroke. Modern techniques have isolated groups of compounds from XXMD which have shown therapeutic effects, such as dilating blood vessels, inhibiting thrombosis, suppressing oxidative stress, attenuating nitric oxide induced damage, protecting the blood brain barrier and the neurovascular unit. However, which of the active compounds is responsible for its therapeutic effects is still unknown. Emerging studies have screened and tested these active compounds aiming to find individual compounds that can be used as drugs to treat stroke. The present study summarized both clinical evidence of XXMD in managing stroke and experimental evidence on its molecular mechanisms that have been reported recently using advanced techniques. A new perspective has also been discussed with an aim to provide new targets that can be used for screening active compounds from XXMD.

Highlights

  • Stroke is the second leading cause of death worldwide, most of which is ischemic strokes (Chang 2015; Katan and Luft, 2018)

  • XXMD is an effective prescription for the treatment of stroke, which is a breakthrough in the management of stroke in the history of Chinese medicine

  • Other clinical studies combined XXMD with Gegen [Pueraria montana var. lobata (Willd.) Maesen and S.M.Almeida ex Sanjappa and Predeep] Decoction (Wang and Qian, 2017), or with Huang Qi (Astragalus mongholicus Bunge) (Wei and Wang, 2019), or with Xiongdansan Decoction (Li and Cui, 2012) to treat acute ischemic stroke. They all showed that XXMD in combination with other ingredients significantly alleviated symptoms and decreased the National Institutes of Health Stroke Scale (NIHSS) compared with conservative treatments

Read more

Summary

INTRODUCTION

Stroke is the second leading cause of death worldwide, most of which is ischemic strokes (Chang 2015; Katan and Luft, 2018). DAWN (Katan and Luft, 2018; Nogueira et al, 2018) and DIFFUSE (Albers et al, 2018) expanded the time window for intravascular therapies with perfusion imaging, the percentage of patients with hyperacute ischemic stroke receiving these therapies remains to be investigated. XXMD is an effective prescription for the treatment of stroke, which is a breakthrough in the management of stroke in the history of Chinese medicine. It was recorded in “Beiji Qianjin Yaofang Zhufeng” of Qianjin Yaofang (Tang dynasty- Simiao Sun), and later included in “Medical Prescriptions” and “Tangtou Gejue”.

Clinical Efficacy of XXMD
COMPONENTS AND ACTIVE COMPOUNDS
Scientific name
Prescription function
ACTIVE INGREDIENTS OR COMPOUNDS
Regulate blood flow status brain protection
Findings
AUTHOR CONTRIBUTIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call